Precision Expression: Accelerating Complex Biotherapeutic Production In Cho Cells

2026 29:42
Synopsis
Discover how a novel cell line development platform is transforming the production of complex biotherapeutics. This expert ...

You Might Also Like

Next Generation CHO Transient Expression 1:33
Next Generation Cho Transient Expression
2022
CHOgro® High Yield Expression System: Achieve Higher Titers Faster in Suspension CHO Cells 31:39
Chogro® High Yield Expression System: Achieve Higher Titers...
2022
ExpiCHO: Transient CHO Expression Protocol 8:31
Expicho: Transient Cho Expression Protocol
2016
Freedom® CHO-S® 1:12
Freedom® Cho-s®
2019
CHO Expression Platform: The Workhorse of Protein Expression in Pharmaceutical Industry 39:56
Cho Expression Platform: The Workhorse Of Protein Expression...
2022
CHO cells - Chinese hamster ovary cells used in molecular biology and pharmaceutical biotechnology 0:44
Cho Cells - Chinese Hamster Ovary Cells Used In Molecular Bi...
2023
CHOZN® GS-/- cell line. Accelerate your upstream process development 1:44
Chozn® Gs-/- Cell Line. Accelerate Your Upstream Process De...
2020
Accelerating Bio-Production Using ExpiCHO Stable Production Medium 24:27
Accelerating Bio-production Using Expicho Stable Production ...
2019
ExpiCHO™ Expression System expression protocol - 한국어 8:31
Expicho™ Expression System Expression Protocol - 한국어
2017
Streamlining Cell Line Development for Faster Biologics Production 0:30
Streamlining Cell Line Development For Faster Biologics Prod...
2026
High-Throughput Microbioreactor System-Production: Model IgG1 In CHO Cells l Protocol Preview 2:01
High-throughput Microbioreactor System-production: Model Igg...
2023
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
Ssvid
MP4 & MP3 • HD Quality • Browser Extension Available
Download
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.